JiangXi Tianxin Pharm Co Ltd Market Cap ($1.59 Billion)
Market Cap & Net Worth: JiangXi Tianxin Pharm Co Ltd (603235)
JiangXi Tianxin Pharm Co Ltd market cap. JiangXi Tianxin Pharm Co Ltd (SHG:603235) has a market capitalization of $1.59 Billion (CN¥10.87 Billion) as of November 7, 2026. Listed on the SHG stock exchange, this China-based company holds position #6790 globally and #1376 in its home market, demonstrating a -0.32% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying JiangXi Tianxin Pharm Co Ltd's stock price CN¥24.83 by its total outstanding shares 437780000 (437.78 Million). Also see JiangXi Tianxin Pharm Co Ltd cash conversion from operations for how efficiently the company converts equity into cash flow.
JiangXi Tianxin Pharm Co Ltd Market Cap History (2022–2026)
JiangXi Tianxin Pharm Co Ltd market cap history from 2022 to 2026. Data shows change from $1.78 Billion to $1.59 Billion (-15.26% CAGR). Check JiangXi Tianxin Pharm Co Ltd (603235) share price today for real-time trading data and today's change.
JiangXi Tianxin Pharm Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how JiangXi Tianxin Pharm Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 603235 net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.74x
JiangXi Tianxin Pharm Co Ltd's market cap is 0.74 times its annual revenue
Latest Price to Earnings (P/E) Ratio
2.92x
JiangXi Tianxin Pharm Co Ltd's market cap is 2.92 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $1.78 Billion | $2.30 Billion | $622.12 Million | 0.77x | 2.87x |
| 2023 | $1.51 Billion | $1.88 Billion | $475.85 Million | 0.80x | 3.17x |
| 2024 | $1.64 Billion | $2.21 Billion | $651.22 Million | 0.74x | 2.51x |
| 2025 | $1.73 Billion | $2.35 Billion | $591.58 Million | 0.74x | 2.92x |
Competitor Companies of 603235 by Market Capitalization
Companies near JiangXi Tianxin Pharm Co Ltd in the global market cap rankings as of November 7, 2026. Also see 603235 total assets for a full breakdown of the balance sheet.
Key companies related to JiangXi Tianxin Pharm Co Ltd by market ranking:
- Nestlé S.A (F:NESM): Ranked #87 globally with a market cap of $224.33 Billion USD ( €191.89 Billion EUR).
- Nestle S.A. (SW:NESN): Ranked #101 globally with a market cap of $199.45 Billion USD ( CHF157.76 Billion CHF).
- Danone SA (PA:BN): Ranked #527 globally with a market cap of $51.26 Billion USD ( €43.85 Billion EUR).
- Danone SA (F:BSND): Ranked #668 globally with a market cap of $39.61 Billion USD ( €33.88 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #87 | Nestlé S.A | F:NESM | $224.33 Billion | €94.80 |
| #101 | Nestle S.A. | SW:NESN | $199.45 Billion | CHF87.23 |
| #527 | Danone SA | PA:BN | $51.26 Billion | €68.56 |
| #668 | Danone SA | F:BSND | $39.61 Billion | €13.30 |
Market Capitalization of JiangXi Tianxin Pharm Co Ltd (2022–2026)
Market capitalization of JiangXi Tianxin Pharm Co Ltd from 2022 to today. Between 2022 and today, JiangXi Tianxin Pharm Co Ltd's market cap moved from $1.78 Billion to $ 1.59 Billion, with a yearly change of -15.26%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.59 Billion | -7.93% |
| 2025 | CN¥1.73 Billion | +5.52% |
| 2024 | CN¥1.64 Billion | +8.49% |
| 2023 | CN¥1.51 Billion | -15.38% |
| 2022 | CN¥1.78 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 6th, 2026 the market cap of JiangXi Tianxin Pharm Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.59 Billion USD |
| MoneyControl | $1.59 Billion USD |
| MarketWatch | $1.59 Billion USD |
| marketcap.company | $1.59 Billion USD |
| Reuters | $1.59 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About JiangXi Tianxin Pharm Co Ltd
JiangXi Tianxin Pharmaceutical Co., Ltd. produces and sells vitamins in China. The company offers products of vitamin B6, vitamin B1, Vitamin B5, Vitamin D3, pyridoxine hydrochloride CD grade, thiamine nitrate DC grade, folic acid, biotin, ascorbyl palmitate, vitamin E 500, a-acetyl-"-butyrolactone, ABL, cholesterol, sodium methoxide, L-alanine, and vitamin D3 for use as bulk pharmaceutical chemi… Read more